to 10 ml of LB with 100 µg/mL spectinomycin and 10 µg/ml kanamycin at 37 °C for overnight, followed by 1 L of LB medium containing the same antibiotics. Expression of MtFGE was induced by addition of L-(+)-Arabinose (0.2 % wt/vol) at OD 600 = 0.3. The growth temperature was decreased to 16°C and EcMutS induced 30 m later by addition of IPTG (0.05 mM). Cells were collected after 16h and resuspended in freezing buffer (25 mM Hepes pH 7.8, 300 mM NaCl, 10 % glycerol and 20 mM imidazole). Cell pellets were frozen-thaw three times and sonicated twice, followed by centrifuged at 41000 rpm (Rotor: Ti 60 Beckman) for 1h. The supernatants were then loaded on a Ni-NTA (Qiagen) column equilibrated in Buffer A (25 mM Hepes pH 7.8, 10 % glycerol and 20 mM imidazole) containing 500 mM NaCl, washed with Buffer A containing 500 mM NaCl followed by Buffer A containing 300 mM NaCl and eluted with 20-200 mM Imidazole step in Buffer A plus 300 mM NaCl.
EcMutL expression and partial purification. After transformation with the EcMutL expression
plasmid, BL21 AI cells were cultured at 37°C for 1h, spread on an LB-kanamycin plate, and grown at 37°C overnight. A single colony was transferred to 10 mL of LB containing 10 µg/ml kanamycin at 37°C for overnight, followed by dilution into 1 L of LB containing the same antibiotic. Expression of EcMutL was induced by addition of L-(+)-Arabinose (0.2 % wt/vol) and IPTG (0.2 mM) at OD 600 = 0.3. Cells were collected after 3h and resuspended in freezing buffer (25 mM Hepes pH 7.8, 300 mM NaCl, 10% glycerol and 20 mM imidazole). Cell pellets were frozen-thaw three times and sonicated twice, followed by centrifuged at 41000 rpm (Rotor: Ti 60 Beckman) for 1h. The supernatants were then loaded on a Ni-NTA (Qiagen) column equilibrated in Buffer A (25 mM Hepes pH 7.8, 10 % glycerol and 20 mM imidazole) containing 500 mM NaCl, washed with Buffer A containing 500 mM NaCl followed by Buffer A containing 300 mM NaCl and eluted with a 20-200 mM Imidazole step in Buffer A plus 300 mM NaCl.
EcRecJ expression and partial purification. After transformation with the EcRecJ expression plasmid, BL21 AI cells were cultured at 37°C for 1h, spread on an LB-kanamycin plate, and grown at 37°C overnight. A single colony was transferred to 10 mL of LB containing 10 µg/ml kanamycin at 37°C for overnight, followed by dilution into 1 L of LB containing the same antibiotic. At OD 600 = 0.3 the growth temperature was decreased to 16°C and expression of EcRecJ was induced by addition of L-(+)-Arabinose (0.2% wt/vol) and IPTG (0.2 mM ). Cells were collected after 16h and resuspended in freezing buffer (25 mM Hepes pH 7.8, 300 mM NaCl, 10% glycerol and 20 mM imidazole). Cell pellets were frozen-thaw three times and sonicated twice, followed by centrifuged at 41000 rpm (Rotor: Ti 60 Beckman) for 1h. The supernatants were then loaded on a Ni-NTA (Qiagen) column equilibrated in Buffer A (25 mM Hepes pH 7.8, 10 % glycerol and 20 mM imidazole) containing 500 mM NaCl, washed with Buffer A containing 500 mM NaCl followed by Buffer A containing 300 mM NaCl and eluted with a 20-200 mM Imidazole step in Buffer A plus 300 mM NaCl.
MtFGE expression and purification. After transformation with the MtFGE expression plasmid, BL21 cells were cultured at 37°C for 1h, spread on an LB-ampicillin plate, and grown at 37°C overnight. A single colony was transferred to 10 mL of LB containing 50 µg/ml ampicillin at 37°C for overnight, followed by dilution into 1 L of LB containing the same antibiotic. At OD 600 = 0.3 the growth temperature was decreased to 16°C and expression of MtFGE was induced 30m later by addition of IPTG (0.1 mM). Cells were collected after 16h and resuspended in freezing buffer (25 mM Hepes pH 7.8, 300 mM NaCl, 10% glycerol and 20 mM imidazole). Cells were collected after 16h and resuspended in freezing buffer (25 mM Hepes pH 7.8, 300 mM NaCl, 10 % glycerol and 20 mM imidazole). Cell pellets were frozen-thaw three times and sonicated twice, followed by centrifuged at 41000 rpm (Rotor: Ti 60 Beckman) for 1h. The supernatants were then loaded on a Ni-NTA (Qiagen) column equilibrated in Buffer A (25 mM Hepes pH 7.8, 10 % glycerol and followed by Buffer A containing 150 mM NaCl and eluted with linear 20-200 mM Imidazole gradient in Buffer A plus 150 mM NaCl. MtFGE-containing fractions were dialyzed in storage buffer (25 mM Hepes pH 7.8, 1 mM DTT, 0.1 mM EDTA, 150 mM NaCl, 20 % glycerol) and frozen at -80°C. MtFGE retained full fGly conversion activity in vitro after 1y at -80°C.
MtFGE conversion and fluorophore-labeling. MMR proteins containing an ald 6 -tag and MtFGE (ratio 1:1) were dialyzed together in conversion buffer (50 mM Tris-HCl pH 8.0, 100 mM NaCl, 20 mM Arginine and 0.25 mM DTT) at 4°C for 48h and then dialyzed in labeling buffer (100 mM potassium-phosphate pH 6.4, 0.25 mM DTT, 300 mM NaCl) for overnight. Proteins were then incubated with AlexaFluor or Atto-HiPS dye at 0°C for 48h.
EcMutS purification after labeling. After labeling, EcMutS was diluted with 3 volume of Buffer B (25 mM Hepes pH 7.8, 1 mM DTT, 10 % glycerol) and loaded onto a heparin column, washed with Buffer B plus 100 mM NaCl and eluted with a linear gradient of 100 mM -1 M NaCl. Fractions were visualized on an 8% SDS-PAGE, scanned on a typhoon 9410 (GE Healthcare Life Sciences) and then stained with Coomassie Blue. EcMutS-containing fractions were dialyzed in storage buffer (25 mM Hepes pH 7.8, 1 mM DTT, 0.1 mM EDTA, 150 mM NaCl, 20 % glycerol,) and frozen at -80°C.
EcMutL purification after labeling. After labeling, EcMutL was diluted with 10 volume of labeling buffer without DTT and loaded on a Ni-NTA (Qiagen) column equilibrated in Buffer A (25 mM Hepes pH 7.8, 10 % glycerol and 20 mM imidazole) plus 25 mM NaCl, washed with Buffer A containing 25 mM NaCl and eluted directly on to a ssDNA cellulose column (Affimetrix) with a 20-200 mM Imidazole step in Buffer A plus 25 mM NaCl. The ssDNA cellulose column was washed with Buffer B plus 25 mM NaCl and EcMutL eluted with a 25 mM -1 M NaCl linear gradient.
EcMutL-containing fractions eluting at 80-100 mM NaCl were pooled, diluted with 1 volume Buffer B containing 50 mM NaCl, loaded onto MonoS equilibrated in Buffer B plus 100 mM NaCl, and eluted with a 100 mM -1 M NaCl linear gradient in Buffer B. Fractions were visualized on an 8% SDS-PAGE, scanned on a typhoon 9410 (GE Healthcare Life Sciences) and then stained with Coomassie Blue. EcMutL-containing fractions were dialyzed in storage buffer (25 mM Hepes pH 7.8, 1 mM DTT, 0.1 mM EDTA, 150 mM NaCl, 20 % glycerol) and frozen at -80°C. A 12% SDS-PAGE gel was used to separate labeled and unlabeled EcMutL and quantification was performed using ImageQuant software.
Gel mobility shift assay. A 41 bp Cy3-labeled DNA with or without a central G/T mismatch (3 nM) was inclubated on ice for 15 m with EcMutS (400 nM) in 20 L GS Buffer (25 mM Hepes pH 7.8, 1 mM DTT, 2 mM MgCl 2 , 130 mM NaCl, 15 % glycerol, 100 μg/ml acetylated BSA and 5 ng/μl poly dI· dC). Reactions were immediately loaded and separated on a 5% polyacrylamide (29:1 bis), 4 % glycerol gel in TAE Buffer (40 mM Tris Acetate, 1 mM EDTA). Gels were scanned on typhoon 9410 (GE Healthcare Life Sciences).
Surface plasmon resonance (SPR).
Biotinylated DNA (Table 1) The labeling efficiency of the unknown lanes (Unk % ) was then calculated using Equation 2:
For Figure 3, Figures 4, Figure S5 and Figure S8 , The lanes with highest ratio (R, see above)
were used as references and labeling efficiency were set to 100%, the Relative Labeling Efficiency was calculated using Equation 3.
% = × 100
Equation 3 Single NHBOC cadaverine (4.1 mg, 4.2 mL, 0.02 mmol), and DIPEA (7.9 mg, 10.6 mL, 0.06 mmol). The reaction was stirred at room temperature for 2 h, adsorbed directly onto a Biotage KP C18 HS 1.2 g samplet, and purified on a Biotage KP C18 HS 12 g cartridge using a gradient of 0-100% CH 3 CN in H 2 O. The BOC Cadaverine ATTO488 product was a reddish orange film (7.8 mg, 99% yield).
(
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